Osteopore Limited (ASX:OSX)


right-arrow Created with Sketch. 0 (0%)
MCAP $26.97M
Last trade 13.55pm 28/01/2022 20mins delayed

Latest Announcements

28/01/2022 Price SensitivePSOSXOsteopore Limited
18/01/2022OSXOsteopore Limited
29/12/2021OSXOsteopore Limited
29/12/2021OSXOsteopore Limited
13/12/2021 Price SensitivePSOSXOsteopore Limited
02/12/2021OSXOsteopore Limited
22/11/2021OSXOsteopore Limited
02/11/2021OSXOsteopore Limited

Company Overview

Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. It fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. It also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.

OSX in the news

Osteopore (OSX) has signed a deal with LMT Surgical to distribute its…
Medical technology company Osteopore (OSX) has received binding commitments from sophisticated and…
Medical technology company Osteopore (OSX) has entered a trading halt ahead of…
Meditech company Osteopore (OSX) has seen its share price skyrocket after signing…

Search Previous Announcements